11548974

Source:http://linkedlifedata.com/resource/pubmed/id/11548974

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0034927, umls-concept:C0035201, umls-concept:C0521116, umls-concept:C0796392
pubmed:issue	8
pubmed:dateCreated	2001-9-10
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8712059
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0890-9091
pubmed:author	pubmed-author:ChenH XHX, pubmed-author:ChesonB DBD, pubmed-author:Gore-LangtonR ERE
pubmed:issnType	Print
pubmed:volume	15
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1017, 1020, 1023-6
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:11548974-Clinical Trials as Topic, pubmed-meshheading:11548974-Humans, pubmed-meshheading:11548974-Neoplasms
pubmed:year	2001
pubmed:articleTitle	Clinical trials referral resource: Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab.
pubmed:affiliation	National Cancer Institute, USA.
pubmed:publicationType	Directory